Tag Archives: COVID-19

Over 900,000 U.S. kids to get first COVID-19 shot by end of Wed -White House

WASHINGTON (Reuters) -Over 900,000 U.S. children aged 5-11 are expected to have received their first COVID-19 vaccine shot by the end of Wednesday, White House COVID-19 coordinator Jeff Zients said, as the government ramped up vaccinations of younger children.

The United States on Wednesday began administering Pfizer/BioNTech’s COVID-19 vaccine to children ages 5 to 11, the latest group to become eligible for the shots that provide protection against the illness to recipients and those around them.

“While our program is just fully up and running this week, by the end of the day today, we estimate that over 900,000 kids aged five through 11 will have already gotten their first shot,” Zients said during a briefing with reporters.

The figure comes from a White House analysis of available data from pharmaceutical partners, some states, and localities, Zients said, adding the CDC has not yet collected the full tally.

COVID-19 is the largest vaccine-preventable killer of children in that age group, with 66 children dying from it over the past year, U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky said at the same briefing.

The seven-day average of total COVID-19 cases in the U.S. was flat at about 73,300 over the past week, she said, with the hospitalization rate also flat at 5,000 a day. The seven-day average of daily deaths fell 11% to around 1,000 per day.

(Reporting by Susan Heavey, Alexandra Alper, and Ahmed Aboulenein; Editing by Nick Zieminski and David Gregorio)

Ellume’s COVID-19 home test recall most serious, FDA says

(Reuters) – The U.S. Food and Drug Administration classified the recall of Ellume’s over-the-counter COVID-19 home test as Class 1, the most serious type of recall, after the Australian diagnostic test maker removed some of its tests from the market last month.

Ellume had cited higher-than-acceptable false positive test results for SARS-CoV-2 as the reason for the recall.

A ‘false positive’ indicates that a person has the virus when they actually do not.

The antigen test, which detects proteins from the SARS-CoV-2 virus from a nasal sample, is available without a prescription for use by people above two years of age with or without COVID-19 symptoms.

The agency said on Wednesday there have been 35 complaints of the antigen test giving false positive results, but no death had been reported related to the test.

Ellume has so far recalled 2,212,335 tests in the United States.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)

U.S. government to buy $1 billion more worth of Merck’s COVID-19 pill

By Manas Mishra

(Reuters) – The U.S. government will buy another $1 billion worth of the COVID-19 pill made by Merck & Co Inc and partner Ridgeback Biotherapeutics, the companies said on Tuesday.

The government in June agreed to buy 1.7 million courses of molnupiravir for $1.2 billion and is now exercising options to buy 1.4 million more.

That brings the total secured courses to 3.1 million and worth $2.2 billion. Merck said the government has the right to buy 2 million more courses as part of the contract.

The drug has been closely watched since data last month showed that when given early in the illness it could halve the chances of dying or being hospitalized for those most at risk of developing severe COVID-19.

“Molnupiravir, if authorized, will be among the vaccines and medicines available to fight COVID-19 as part of our collective efforts to bring this pandemic to an end,” said Frank Clyburn, president of Merck’s human health business.

President Joe Biden said on Friday that the United States had also secured millions of doses of Pfizer Inc’s rival antiviral drug, which was shown to cut by 89% the chance of hospitalization or death for adults at risk of severe disease.

The Pfizer negotiations were for a deal similar to the one with Merck – 1.7 million courses of the treatment upfront with an additional option for 3.3 million, a senior U.S. health official said on Tuesday, confirming a New York Times report.

Pfizer Chief Executive Officer Alfred Bourla said on Friday that the company plans to sell its treatment for around the same price for high-income countries as Merck, at roughly $700 for a course of therapy.

Merck expects to produce 10 million courses of the treatment by the end of this year, with at least 20 million set to be manufactured in 2022.

(Reporting by Manas Mishra and Leroy Leo in Bengaluru; Additional reporting by Jeff Mason in Washington; Editing by Anil D’Silva, Arun Koyyur and Sriraj Kalluvila)

U.S. borders reopen, but not for asylum seekers stuck in Mexico

By Kristina Cooke, Mica Rosenberg and Caitlin O’Hara

NOGALES, Mexico (Reuters) – Leo fled his hometown in southern Mexico after his uncle was murdered by gang members and he received death threats. Earlier this year, he, his wife and their two children headed to the U.S.-Mexico border hoping to claim asylum.

After months of waiting, he hoped he would finally get his chance on Monday. But even as U.S. borders opened for travelers vaccinated against COVID-19, they remained closed to asylum seekers.

When Leo, 23, and his family approached the port of entry in Nogales, Mexico with his and his wife’s vaccination cards in hand, they were told by a border official they could not enter and seek asylum.

“I feel dispirited and sad,” said Leo, who asked his last name not be published for fear of reprisals from the gang he fled. President Joe Biden “is just continuing the same policies of Donald Trump.”

Biden has kept in place a controversial U.S. Centers for Disease Control and Prevention (CDC) order, first implemented by his Republican predecessor Trump in March 2020, that allows migrants to be immediately expelled without an opportunity to seek asylum.

The Biden administration has said the CDC’s order, known as Title 42, remains necessary to prevent the spread of COVID-19, as asylum seekers are processed in crowded settings at the border.

Any foreign national attempting to enter the United States without proper documentation will be subject to expulsion regardless of vaccination status, according to the Department of Homeland Security.

Advocates have criticized the Biden administration’s continuation of the expulsion policy as borders reopen.

The idea that a vaccinated asylum seeker is more of a risk than a vaccinated tourist is laughable, said Noah Gottschalk, global policy lead with Oxfam America, one of the advocacy groups suing the Biden administration to overturn the Title 42 order. Gottschalk said the exclusion of vaccinated asylum seekers strengthens the group’s argument that the policy isn’t about public health.

In September, a federal judge ordered the Biden administration to stop expelling family units – parents or legal guardians arriving with their children – under the Title 42 order. The administration appealed, and a higher court put the judge’s ruling on hold as the case moves forward.

Last month, more than 1,300 medical professionals signed letters to the CDC urging it to end the border expulsions order, saying it lacked epidemiological evidence to justify it and put migrants at risk.

New York-based nonprofit Human Rights First has documented more than 7,600 kidnappings and other attacks on migrants stuck in Mexico who were blocked from entering the United States since Biden took office in January.

Leo has been working in construction to pay rent in Nogales, but he says his earnings are not enough to support his family. “They abuse you because they know you are not from here, they pay you what they want,” he said.

He is also worried about his children getting hit by a stray bullet when gunshots ring out at night. The U.S. State Department recommends Americans reconsider travel to the Mexican state of Sonora, where Nogales is located, due to crime and kidnapping.

“We were fleeing a place that was dangerous,” said Leo. “And here it is the same.”

(Reporting by Kristina Cooke in San Francisco, Mica Rosenberg in New York and Caitlin O’Hara in Nogales, Mexico; Editing by Mary Milliken and Karishma Singh)

U.S.-Mexico border reopens after 20 months of COVID disruption

By Lizbeth Diaz and Jose Luis Gonzalez

TIJUANA/CIUDAD JUAREZ, Mexico (Reuters) -There were fewer crossings at the Mexico-United States border than expected on Monday as it reopened to non-essential travel following a 20-month closure due to the COVID-19 pandemic, with many residents staying home to avoid potential chaos.

Officials in the Mexican border city of Tijuana said people did not make the most of restrictions being lifted along the 2,000-mile (3,200-km) border lest they get caught in traffic.

“In the morning, there was no line,” Tijuana resident Claudia Hernandez said as she prepared to enter the United States to go shopping ahead of the Thanksgiving holiday next week.

“Next week we’ll see the massive lines that always form.”

Javier Delgado, a Tijuana transport official, said there were was about 35% less traffic than expected on the city’s border with San Diego, one of the busiest in the world.

On Sunday, hundreds of cars had formed lines stretching back kilometers from Tijuana, fueling fears the reopening could become a problem. But traffic advanced steadily.

In the Mexican city of Ciudad Juarez opposite El Paso, Texas, about 20 people lined up early on Monday before crossing and embracing family on the other side of the border.

“We thought they were going to tell us again they had decided not to open it,” said Lorena Hernandez, stroking her grown-up daughter’s hair and smiling broadly after they were reunited in El Paso for the first time since March 2020. “I said: If they don’t reopen, I’m going to take a plane.”

Still, differing rules over coronavirus vaccines threaten to hold up other family reunions, while the prospect of some curbs easing has also encouraged migrants to try their luck seeking U.S. asylum, posing a new test for the Biden administration.

Some inoculated Mexicans will not be able to enter the United States immediately if they received vaccines in Mexico that have not been approved by the World Health Organization, such as China’s CanSino and Russia’s Sputnik V.

“I never imagined that because I got the CanSino vaccine I wouldn’t be able to cross,” lamented Donato Suarez, a driver at a private university in Tijuana who had hoped to visit relatives in the United States he has not seen for nearly two years.

“We even had plans to do something when the border reopened,” he added, noting around 300 people where he works are in the same predicament. “We’ll have to wait.”

(Reporting by Lizbeth Diaz; Editing by Michael Perry and Jonathan Oatis)

German coronavirus infection rate hits highest since pandemic began

FRANKFURT (Reuters) -Germany’s coronavirus infection rate has risen to its highest level since the start of the pandemic, public health figures showed on Monday, and doctors warned they will need to postpone scheduled operations in coming weeks to cope.

The seven-day incidence rate – the number of people per 100,000 to be infected over the last week – rose to 201.1, higher than a previous record of 197.6 in December last year, the figures from the Robert Koch Institute showed on Monday.

The number of confirmed coronavirus cases rose to 4,782,546 from 4,767,033 a day earlier. The number of deaths increased by 33 to a total of 96,558.

Christian Karagiannidis, scientific director at the DIVI association for intensive and emergency medicine, said an expected rise in coronavirus cases in coming weeks meant some scheduled operations would have to be postponed.

“We will only be able to cope with the burden of all emergencies if savings are made somewhere else, though definitely not with surgical cancer treatments,” he told the Augsburger Allgemeine newspaper.

Germany has already had to relocate some patients from regions with overburdened hospitals.

The three German parties in talks to form a coalition government by early December have agreed not to extend a nationwide state of emergency.

Instead, they presented a draft law late on Monday that would amend existing legislation to allow for measures such as compulsory face masks and social distancing in public spaces to continue to be enforced until March next year.

The draft law is due to be presented to the Bundestag lower house of parliament on Thursday and voted on in a special session a week later.

Bavaria state premier Markus Soeder earlier called for more decisive action in view of the new peak in the incidence rate. More needs to be done “than a little compulsory testing in old people’s homes,” he told Deutschlandfunk radio.

He called for tests to be offered free of charge again, vaccination centers to be reactivated and for states and the federal government to coordinate their strategies. Germany has abolished free testing to incentivize people to get vaccinated.

(Writing by Vera Eckert, Paul Carrel and Sarah Marsh, Additional Reporting by Alexander Ratz; editing by Chizu Nomiyama, Mark Heinrich and Alex Richardson)

Russia ends workplace shutdown but COVID numbers stay high

By Tom Balmforth

MOSCOW (Reuters) – Most Russians went back to work on Monday for the first time in more than a week as a nationwide workplace shutdown was lifted across most regions, even though the numbers of new COVID-19 cases and deaths are hovering near record daily highs.

President Vladimir Putin announced last month that Oct. 30 to Nov. 7 would be paid “non-working days” – an attempt to slow the surge in cases by imposing the strictest nationwide restrictions since the early months of the pandemic last year.

But officials on Monday reported 1,190 nationwide coronavirus-related deaths in the last 24 hours, higher than in the days before the enforced work break and just five short of the record reported last Thursday.

There were 39,400 new COVID-19 cases, down from a peak of 41,335 on Saturday.

The Kremlin said it was early to judge the impact of the shutdown yet, but it cited Moscow’s mayor, a close Putin ally, as saying the epidemic in the capital was stabilizing.

Despite developing one of the first vaccines against COVID-19 infection last year, Russia has failed to persuade swathes of the population to accept it. Only around 40 percent of the population is immunized.

Immunologist Nikolay Kryuchkov told Reuters he was skeptical of the effectiveness of the work pause, which only a handful of Russia’s more than 80 regions have chosen to extend into this week.

“I think it will either have a weak effect or a very weak effect,” Kryuchkov said. “It has to be longer and fuller… This is not the same as a European lockdown. It’s a much softer version.”

While people were not meant to work during the lockdown, there was nothing to stop them socializing or travelling in Russia or abroad. Travel agents reported a boom in people flying off on foreign beach holidays.

In Moscow, all shops apart from pharmacies and supermarkets were meant to close, but some pubs and beauty salons were still working.

Kryuchkov said rather than relaxing the curbs, regions such as Moscow and St Petersburg should be expanding them and keeping them in place for longer.

“I fear there is going to be a significant period in which we stay at the same point (in the pandemic) and then it will go down and the rate is going to slowly fall. That is not a very good scenario,” he said.

The Kremlin has said it is up to regional authorities to tailor their lockdowns to match the severity of the outbreaks they face.

Many regions that have lifted the workplace shutdown will now require visitors to present a QR code on their mobile phones when visiting cafes, restaurants or shopping centers to prove they have been vaccinated or previously had the virus.

The situation in the region surrounding Moscow remained “tense”, but the number of people being rushed to hospital has stabilized over the last week, a senior local health official was quoted by TASS news agency as saying.

The recent surge in COVID-19 inpatients has put oxygen supplies under strain, and the Russian navy’s Baltic Fleet said it had handed over five tonnes of liquefied oxygen to help treat hospital patients, the Interfax news agency reported.

(Reporting by Tom Balmforth, Gleb Stolyarov, Maria Kiselyova, Polina Nikolskaya; Editing by Mark Trevelyan and Peter Graff)

U.S. weekly jobless claims near 20-month low; labor costs surge

By Lucia Mutikani

WASHINGTON (Reuters) – The number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum amid a significant improvement in public health, though supply constraints remain.

The tightening labor market is driving up wages as companies scramble for workers, contributing to keeping inflation high. Labor costs surged in the third quarter, other data showed on Thursday, with productivity sinking at its steepest pace in 40 years. The Federal Reserve announced on Wednesday that it would this month start scaling back the amount of money it is pumping into the economy through monthly bond purchases.

“Firms are reluctant to lay off workers with strong demand and labor in short supply,” said Gus Faucher, chief economist at PNC Financial in Pittsburgh, Pennsylvania. “The big open question is what is happening to the millions of people who lost their benefits in September, or saw their benefits drop.”

Initial claims for state unemployment benefits fell 14,000 to a seasonally adjusted 269,000 for the week ended Oct. 30, the Labor Department said. That was the lowest level since the middle of March in 2020, when mandatory business closures were being enforced to slow the first wave of COVID-19 infections. Claims have now declined for five straight weeks.

Unadjusted claims, which economists say offer a better read of the labor market, fell 7,114 to 240,216 last week. There were significant declines in filings in Missouri and Florida, which offset increases in California and Kentucky.

Claims in Kentucky were likely boosted by temporary layoffs in the automobile sector as motor vehicle manufacturers cut production because of scarce semiconductors.

The summer wave of infections driven by the Delta variant has subsided, encouraging more Americans to travel, dine out and frequent sporting venues among activities that were curtailed by the resurgence in cases. The Delta variant and shortages of goods contributed to restricting economic growth to its slowest pace in more than a year last quarter.

Claims, which have declined from a record high of 6.149 million in early April 2020, are now within a range that is generally viewed as consistent with a healthy labor market.

The number of people continuing to receive benefits after an initial week of aid dropped 134,000 to 2.105 million in the week ended Oct. 23. That was also the lowest level since the middle of March in 2020. The number of people receiving aid has declined by around 75% since early September when government-funded benefits expired.

Falling claims augur well for October’s employment report due on Friday. According to a Reuters survey of economists, nonfarm payrolls likely rose by 450,000 jobs. The economy created 194,000 jobs in September, the fewest in nine months.

U.S. stocks opened higher. The dollar rose against a basket of currencies. U.S. Treasury yields fell.

WORKER SHORTAGE

Expectations for an acceleration in job gains were bolstered by the ADP National Employment Report on Wednesday showing strong growth in private payrolls in October. The Conference Board’s labor market differential – derived from data on consumers’ views on whether jobs are plentiful or hard to get – hit a 21-year high.

But relentless worker shortages remain an obstacle. Caregiving needs during the pandemic, fears of contracting the coronavirus, early retirements and careers changes as well as an aging population have left businesses with 10.4 million unfilled jobs as of the end of August.

Fed Chair Jerome Powell told reporters on Wednesday that “these impediments to labor supply should diminish with further progress on containing the virus, supporting gains in employment and economic activity.”

There are concerns that the White House’s vaccine mandate, which applies to federal government contractors and businesses with 100 or more employees, could add to the worker shortages.

A report on Thursday from global outplacement firm Challenger, Gray & Christmas showed job cuts announced by U.S.-based employers increased 27.5% in October to 22,822, the highest since May. It said 22% of the layoffs were people who refused to be vaccinated as per company requirements.

“The issue could push people out of the labor force or slow re-entry as people extend their searches for either employers not enforcing the mandate or workplaces where it doesn’t apply,” said Ryan Sweet, a senior economist at Moody’s Analytics in West Chester, Pennsylvania.

With workers scarce, companies are raising wages. A second report from the Labor Department on Thursday showed unit labor costs, the price of labor per single unit of output, increased at an 8.3% annualized rate in the third quarter after rising at a 1.1% pace in the April-June quarter.

Labor costs rose at a 4.8% rate compared to a year ago. The report followed on the heels of news last month that wage growth in the third quarter was the largest on record. Strong wage gains, together with rising rents, challenge the Fed’s narrative that high inflation is transitory.

“The rise will add to concerns about inflation becoming more entrenched and/or the growing risk to profits, as businesses are not able to offset higher wage costs via productivity gains,” said Sarah House, a senior economist at Wells Fargo in Charlotte, North Carolina.

Worker productivity fell at a 5.0% rate last quarter, the biggest drop since the second quarter of 1981. That followed a 2.4% growth pace in the April-June period.

A third report from the Commerce Department showed the trade deficit surged 11.2% to a record $80.9 billion in September.

(Reporting By Lucia Mutikani; Editing by Chizu Nomiyama and Andrea Ricci)

Biden COVID-19 vaccine mandate for private-sector workers to begin Jan. 4

By Nandita Bose, David Shepardson and Ahmed Aboulenein

WASHINGTON (Reuters) -President Joe Biden will enforce a federal mandate that workers at U.S. companies with at least 100 employees be vaccinated against COVID-19 or be tested weekly starting on Jan. 4, a reprieve to businesses facing labor shortages during the holiday season, U.S. officials said on Thursday.

Biden’s separate vaccine requirement for federal contractors has been delayed a month to Jan. 4, officials added, while millions of workers in healthcare facilities and nursing homes participating in the Medicare and Medicaid government healthcare programs will need to get their shots by the same date.

The action on the private-sector vaccinations was taken under the U.S. Occupational Safety and Health Administration’s (OSHA) emergency authority over workplace safety, officials said. The mandate applies to 84.2 million workers at 1.9 million private-sector employers. Another 18.5 million workers for those employers are exempt because they either work remotely or outside all the time, OSHA said.

“While I would have much preferred that requirements not become necessary, too many people remain unvaccinated for us to get out of this pandemic for good. So I instituted requirements – and they are working,” Biden said in a statement.

OSHA estimates that 31.7 million of covered workers are unvaccinated and 60% of employers will require vaccinations, up from 25% today, resulting in another 22.7 million employees getting vaccinated.

The administration’s various vaccine rules cover 100 million employees, about two-thirds of the U.S. workforce, the White House said. OSHA will consider during a 30-day public comment on the private-sector rule expanding the mandate to cover businesses with fewer than 100 workers, officials said.

The private-sector mandate is likely to trigger legal challenges and a legal battle hinging upon on the rarely used law on which the action was based and questions over the constitutional limits of federal power and authority over healthcare practices. The administration said the action falls well within OSHA’s authority.

The U.S. Chamber of Commerce, the nation’s largest business lobbying group, said the administration “made some significant adjustments” in the rule that reflect concerns raised by the business community.

Other industry groups voiced concerns. The Retail Industry Leaders Association said the 60-day implementation timeline is insufficient and that it wanted 90 days.

“It falls short of the 75 days the government originally gave itself to implement a mandate on federal employees – a period they have now lengthened for government contractors while imposing a much stricter standard on the private sector,” the group said.

Some of the nation’s largest unions such as the United Auto Workers (UAW) said they will review the rule to determine how it affects current workplace protocols.

The 490-page regulation is known as a Emergency Temporary Standard (ETS). Senate Republicans said they would try to repeal it using a law known as the Congressional Review Act.

“The administration wouldn’t move forward unless they thought that they could defend it legally. … I think the constitutional challenges are all going to fail,” said Donald Verrilli, U.S. solicitor general during former President Barack Obama’s administration, told Reuters.

DANGEROUS SURGE

Biden in September unveiled plans for the mandate, seeking to increase vaccination rates amid a dangerous surge in COVID-19 cases and get more people back to work. In meetings with companies and industry groups representing retailers, logistics firms and construction workers, executives asked the administration to delay implementation until after the New Year, citing concerns about worker shortages during the important holiday season.

Employers will not be required to provide or pay for tests. The administration estimates that about 5% of employees covered by the rule will seek and receive religious or medical accommodations.

Failure to comply with the mandate would trigger fines of about $14,000 per violation, which would increase with several violations, officials said. They did not specify whether workers would be fired for refusal to be vaccinated or tested.

A company can have all its workers unvaccinated under the rule as long as they get tested regularly and wear masks, officials said.

A recalcitrant minority of Americans has refused to be vaccinated. About 70% of U.S. adults have been fully vaccinated and 80% have received at least one shot, according to the latest data. An average of about 1,100 Americans are dying daily from COVID-19, most of them unvaccinated. COVID-19 has killed more than 745,000 Americans.

“We have to do what is right for our workforce,” Labor Secretary Marty Walsh told reporters.

The rule for healthcare workers covers more than 10 million people, of which around 70% have already been vaccinated, officials said. It applies to around 76,000 healthcare providers that receive Medicare or Medicaid reimbursements including hospitals, nursing homes, dialysis centers, ambulatory surgical settings and home-health agencies.

The administration said it stopped short of requiring further workplace measures involving workplace distancing, barriers, ventilation and sanitation.

(Reporting by Nandita Bose, David Shepardson and Ahmed Aboulenein in Washington and Tom Hals in Wilmington, Delaware; Editing by Will Dunham, Chris Sanders and Shri Navaratnam)

COVID cases break records across Europe as winter takes hold

By Krisztina Than and Nikolaj Skydsgaard

BUDAPEST (Reuters) – Coronavirus infections are hitting record levels in many countries across Europe as winter takes hold, prompting a call for action from the World Health Organization which described the new wave as a “grave concern.”

Soaring numbers of cases, especially in Eastern Europe, have prompted debate on whether to reintroduce curbs on movement before the Christmas holiday season and on how to persuade more people to get vaccinated.

That conversation comes as some countries in Asia, with the notable exception of China, reopen their tourism sectors to the rest of the world.

“The current pace of transmission across the 53 countries of the European Region is of grave concern,” regional WHO head Hans Kluge said, adding that the spread was exacerbated by the more transmissible Delta variant.

The virus spreads faster in the winter months when people gather indoors.

Kluge warned earlier that if Europe followed its current trajectory, there could be 500,000 COVID-related deaths in the region by February.

“We must change our tactics, from reacting to surges of COVID-19, to preventing them from happening in the first place,” he said.

The region saw a 6% increase in new cases last week, with nearly 1.8 million new cases, compared to the week before. The number of deaths rose 12% in the same period.

Germany, Europe’s biggest economy, reported 33,949 new infections, the highest daily increase since the start of the pandemic last year. Cases in Russia and Ukraine are soaring.

Austria’s daily new coronavirus infections surged towards a record set a year ago, making a lockdown for the unvaccinated ever more likely.

COVID-19 prevalence in England rose to its highest level on record in October, Imperial College London said, led by a high numbers of cases in children and a surge in the southwest.

Slovakia reported 6,713 new cases, also a record, while daily new cases in Hungary more than doubled from last week to 6,268. Poland, Eastern Europe’s biggest economy, reported 15,515 daily cases on Thursday, the highest figure since April. Croatia and Slovenia on Thursday both reported record daily infections.

CHINA ON ALERT AHEAD OF OLYMPICS

China is also on high alert at ports of entry to reduce the risk of COVID-19 cases entering from abroad, and has stepped up restrictions amid a growing outbreak less than 100 days before the Beijing Winter Olympics.

Authorities have also tightened curbs in the capital ahead of a major gathering of the top members of the Communist Party next week.

Since mid-October, over 700 locally transmitted cases with confirmed symptoms have been reported in China. While the number is tiny compared with other countries, it has led to a growing wave of restrictions under Beijing’s zero-tolerance policy.

In Central Europe, Hungary has trimmed its 2021 GDP growth projection to 6.8% from 7.0-7.5% due to a rise in inflation, energy prices, and the risks stemming from COVID-19, the finance minister said, flagging the possibility of some new restrictions in a country where there are currently hardly any curbs in place.

Slovakia’s Finance Ministry cut its forecasts for 2021 and 2022 growth in September, saying a new wave of COVID-19 cases will hit consumer demand and the labor market at the end of the year although the impact will not be as strong as earlier in the pandemic. Poland’s central bank left its projections unchanged.

FRESH CURBS

The Hungarian government has urged people to take up vaccines and last week announced mandatory vaccinations at state institutions, also empowering private companies to make jabs mandatory for employees if they believe that is necessary.

Romania – where hospitals cannot cope with a surge in COVID-19 patients – the Czech Republic, Slovakia and Poland have all tightened rules on mask wearing and introduced measures to curb infections.

The Czech Republic has introduced a requirement for restaurant customers to show proof of vaccination or a test. It also has tough mask regulations and some children are again being tested in schools in areas where cases are higher.

In Poland, mask wearing is mandatory in enclosed public spaces while cinemas, theatres and hotels have a 75% capacity limit. The Hungarian government has not replied to Reuters questions on potential measures.

(Reporting by Krisztina Than in Budapest and Nicolaj Skydsgaard in Copenhagen; Additional reporting by Jason Hovet, Alan Charlish and bureaux worldwide; Writing by Nick Macfie; Editing by Frances Kerry)